Tensions in ethics and policy created by national precision medicine programs

Human Genomics

Volumn 12, Issue 1, 2018, Pages

  Minari, Jusaku ^a   Brothers, Kyle B ^b   Morrison, Michael ^c  

^a KYOTO UNIVERSITY   (Japan)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Consent; Genomics; Insurance; Precision medicine; Privacy; Sustainability

Indexed keywords

ARTICLE; GENE SEQUENCE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; JAPAN; LANDSCAPE; MEDICAL ETHICS; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PUBLIC-PRIVATE PARTNERSHIP; REGULATORY MECHANISM; UNITED KINGDOM; UNITED STATES; ETHICS; GENETICS; HUMAN GENOME; INFORMED CONSENT; TRANSLATIONAL RESEARCH;

GENOME, HUMAN; GENOMICS; HUMANS; INFORMED CONSENT; JAPAN; PRECISION MEDICINE; TRANSLATIONAL MEDICAL RESEARCH; UNITED KINGDOM; UNITED STATES;

EID: 85055620046     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/s40246-018-0151-9     Document Type: Article

References (65)

1. Marx V. The DNA of a nation. Nature. 2015;524:503-5. https://doi.org/10.1038/524503a.
2. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793-5. https://doi.org/10.1056/NEJMp1500523.
3. Wright CF, Middleton A, Burton H, Cunningham F, Humphries SE, Hurst J, et al. Policy challenges of clinical genome sequencing. BMJ. 2013;347:f6845. https://doi.org/10.1136/bmj.f6845.
4. Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15:258-67. https://doi.org/10.1038/gim.2012.157.
5. Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med. 2015;12:43-51.
6. Korngiebel DM, Thummel KE, Burke W. Implementing precision medicine: the ethical challenges. Trends Pharmacol Sci. 2017;38:8-14. https://doi.org/10.1016/j.tips.2016.11.007. Epub 2016 Dec 7
7. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565-74. https://doi.org/10.1038/gim.2013.73.
8. Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249-55. https://doi.org/10.1038/gim.2016.190.
9. Van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, et al. Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2013;21:580-4. https://doi.org/10.1038/ejhg.2013.46.
10. Day S, Coombes RC, McGrath-Lone L, Schoenborn C, Ward H. Stratified, precision or personalised medicine? Cancer services in the 'real world' of a London hospital. Sociol Health Illn. 2017;39:143-58. https://doi.org/10.1111/1467-9566.12457.
11. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 2007;6:287-93. https://doi.org/10.1038/nrd2251.
12. Coathup V, Teare HJA, Minari J, Yoshizawa G, Kaye J, Masanori MP, et al. Using digital technologies to engage with medical research: views of myotonic dystrophy patients in Japan. BMC Med Ethics. 2016;17:51. https://doi.org/10.1186/s12910-016-0132-2.
13. Aitken M, de St Jorre J, Pagliari C, Jepson R, Cunningham-Burley S. Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies. BMC Med Ethics. 2016;17:73. https://doi.org/10.1186/s12910-016-0153-x.
14. Department of Health, Annual report of the Chief Medical Officer 2016. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/631043/CMO-annual-report-generation-genome.pdf.
15. How science fares in the U.S. budget deal. Science. 2017. http://www. sciencemag.org/news/2017/05/how-science-fares-us-budget-deal.
16. Green RC, Goddard KA, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, et al. Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine. Am J Hum Genet. 2016;99: 246. https://doi.org/10.1016/j.ajhg.2016.06.002.
17. Headquarters for Healthcare Policy. The healthcare policy. 2014. http://www. kantei.go.jp/jp/singi/kenkouiryou/en/pdf/policy.pdf
18. Normile D. Biomedical research. Japan's 'NIH' starts with modest funding but high ambitions. Science. 2015;348:616. https://doi.org/10.1126/science. 348.6235.616.
19. Yamaguchi-Kabata Y, Yasuda J, Tanabe O, Suzuki Y, Kawame H, Fuse N, et al. Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals. J Hum Genet. 2017 (epub ahead of print); https://doi.org/10.1038/s10038-017-0347-1.
20. Adachi T, Kawamura K, Furusawa Y, Nishizaki Y, Imanishi N, Umehara S, et al. Japan's initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey. Eur J Hum Genet. 2017;25:1025-8. https://doi.org/10.1038/ejhg.2017.106.
21. Friedman CP, Wong AK, Blumenthal D. Achieving a nationwide learning health system. Sci Transl Med. 2010;2:57cm29. https://doi.org/10.1126/scitranslmed.3001456.
22. Slutsky JR. Moving closer to a rapid-learning health care system. Health Aff. 2007;26:w122-4. https://doi.org/10.1377/hlthaff.26.2.w122.
23. Etheredge LM. A rapid-learning health system. Health Aff. 2007;26:w107-18. https://doi.org/10.1377/hlthaff.26.2.w107.
24. Etheredge LM. Rapid learning: a breakthrough agenda. Health Aff. 2014;33:1155-62. https://doi.org/10.1377/hlthaff.2014.0043.
25. ACMG Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet Med. 2013;15:748-9. https://doi.org/10.1038/gim.2013.94.
26. Karow, J. (2017) As 100K genomes project returns patient reports, NHS prepares to commission WGS for diagnostics. GenomeWeb 06 November 2017. Available at: https://www.genomeweb.com/molecular-diagnostics/100k-genomes-project-returns-patient-reports-nhs-prepares-commission-wgs (Accessed 12 Aug 2017).
27. Budin-Ljøsne I, Teare HJ, Kaye J, Beck S, Bentzen HB, Caenazzo L, et al. Dynamic consent: a potential solution to some of the challenges of modern biomedical research. BMC Med Ethics. 2017;18:4. https://doi.org/10.1186/s12910-016-0162-9.
28. Tabor HK, Jamal SM, Yu JH, Crouch JM, Shankar AG, Dent KM, et al. My46: a Web-based tool for self-guided management of genomic test results in research and clinical settings. Genet Med. 2017;19:467-75. https://doi.org/10.1038/gim.2016.133.
29. Minari J, Teare H, Mitchell C, Kaye J, Kato K. The emerging need for family-centric initiatives for obtaining consent in personal genome research. Genome Med. 2014;6:118. https://doi.org/10.1186/s13073-014-0118-y.
30. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet. 2013;93:631-40. https://doi.org/10.1016/j.ajhg.2013.08.006.
31. Lindor NM, Thibodeau SN, Burke W. Whole-genome sequencing in healthy people. Mayo Clin Proc. 2017;92:159-72. https://doi.org/10.1016/j.mayocp. 2016.10.019.
32. Sanderson SC. Genome sequencing for healthy individuals. Trends Genet. 2013;29:556-8. https://doi.org/10.1016/j.tig.2013.08.005.
33. Sanderson SC, Linderman MD, Suckiel SA, Diaz GA, Zinberg RE, Ferryman K, et al. Motivations, concerns and preferences of personal genome sequencing research participants: baseline findings from the HealthSeq project. Eur J Hum Genet. 2016;24:14-20. https://doi.org/10.1038/ejhg.2015.118.
34. Cassa CA, Tong MY, Jordan DM. Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals. Hum Mutat. 2013;34:1216-20. https://doi.org/10.1002/humu.22375.
35. Taylor DH Jr, Cook-Deegan RM, Hiraki S, Roberts JS, Blazer DG, Green RC. Genetic testing for Alzheimer's and long-term care insurance. Health Aff. 2010;29:102-8. https://doi.org/10.1377/hlthaff.2009.0525.
36. Joly Y, Braker M, Le Huynh M. Genetic discrimination in private insurance: global perspectives. New Genet Soc. 2010;29:351-68. https://doi.org/10.1080/14636778.2010.528189.
37. Otlowski M, Taylor S, Bombard Y. Genetic discrimination: international perspectives. Ann Rev Genomics Hum Genet. 2012;13:433-54. https://doi.org/10.1146/annurev-genom-090711-163800.
38. Joly Y, Feze IN, Song L, Knoppers BM. Comparative approaches to genetic discrimination: chasing shadows? Trends Genet. 2017;33:299-302. https://doi.org/10.1016/j.tig.2017.02.002.
39. Green RC, Lautenbach D, McGuire AL. GINA, genetic discrimination, and genomic medicine. N Engl J Med. 2015;372:397-9. https://doi.org/10.1056/NEJMp1404776.
40. Joly Y, Burton H, Knoppers BM, Feze IN, Dent T, Pashayan N, et al. Life insurance: genomic stratification and risk classification. Eur J Hum Genet. 2014;22:575-9. https://doi.org/10.1038/ejhg.2013.228.
41. Yoshizawa G, Sasongko TH, Ho CH, Kato K. Social and communicative functions of informed consent forms in East Asia and beyond. Front Genet. 2017;8:99. https://doi.org/10.3389/fgene.2017.00099.
42. Branum R, Wolf SM. International policies on sharing genomic research results with relatives: approaches to balancing privacy with access. J Law Med Ethics. 2015;43:576-93. https://doi.org/10.1111/jlme.12301.
43. Dheensa S, Crawford G, Salter C, Parker M, Fenwick A, Lucassen A. How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study. Familial Cancer. 2017 (epub ahead of print). https://doi.org/10.1007/s10689-017-9994-9.
44. Dheensa S, Fenwick A, Lucassen A. Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals. BMJ Open. 2017;7:e012443. https://doi.org/10.1136/bmjopen-2016-012443.
45. Dheensa S, Fenwick A, Lucassen A. 'Is this knowledge mine and nobody else's? I don't feel that.' Patient views about consent, confidentiality and information sharing in genetic medicine. J Med Ethics. 2016;42:174-9. https://doi.org/10.1136/medethics-2015-102781.
46. Rothstein MA. HIPAA privacy rule 2.0. J Law Med Ethics. 2013;41:525-8.
47. Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, Ministry of Economy, Trade and Industry. Ethical guidelines for human genome/gene analysis research. 2001 (fully revised in 2004 and 2013, partially revised in 2005, 2008, 2014 and 2017).
48. Parkman AA, Foland J, Anderson B, Duquette D, Sobotka H, Lynn M, et al. Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections. J Genet Couns. 2015;24:512-21. https://doi.org/10.1007/s10897-014-9771-y.
49. Wauters A, Van Hoyweghen I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016;61:275-82. https://doi.org/10.1038/jhg.2015.151.
50. Ikeda W. The public's attitudes towards the use of genetic information for medical purposes and its related factors in Japan. Community Genet. 2008;11:18-25. https://doi.org/10.1159/000111636.
51. Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018 (epub ahead of print). https://doi.org/10.1038/gim.2017.247.
52. Chalmers D, Nicol D, Kaye J, Bell J, Campbell AV, Ho CW, et al. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era. BMC Med Ethics. 2016;17:39. https://doi.org/10.1186/s12910-016-0124-2.
53. Caulfield T, Borry P, Gottweis H. Industry involvement in publicly funded biobanks. Nat Rev Genet. 2014;15:220. https://doi.org/10.1038/nrg3704.
54. Watson PH, Mossback SY, Carter C, O'Donoghue S, Cheah S, Matzke LA, et al. A framework for biobank sustainability. Biopreserv Biobank. 2014;12:60-8. https://doi.org/10.1089/bio.2013.0064.
55. Hofman P, Bréchot C, Zatloukal K, Dagher G, Clément B. Public-private relationships in biobanking: a still underestimated key component of open innovation. Virchows Arch. 2014;464:3-9. https://doi.org/10.1007/s00428-013-1524-z.
56. Zawati MH, Borry P, Howard HC. Closure of population biobanks and direct-to-consumer genetic testing companies. Hum Genet. 2011;130:425-32. https://doi.org/10.1007/s00439-011-1019-4.
57. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, et al. Funding of US biomedical research, 2003-2008. JAMA. 2010;303:137-43. https://doi.org/10.1001/jama.2009.1987.
58. Wellcome Trust. Public attitudes to commercial access to health data. 2016. https://wellcome.ac.uk/sites/default/files/public-attitudes-to-commercialaccess-to-health-data-summary-wellcome-mar16.pdf
59. Hawkes N. NHS data sharing deal with Google prompts concern. BMJ. 2016;353:i2573. https://doi.org/10.1136/bmj.i2573.
60. Hunter P. The big health data sale: as the trade of personal health and medical data expands, it becomes necessary to improve legal frameworks for protecting patient anonymity, handling consent and ensuring the quality of data. EMBO Rep. 2016;17:1103-5. https://doi.org/10.15252/embr. 201642917.
61. Regeneron Press Release. Regeneron and Geisinger Health System announce major human genetics research collaboration. 2014. Available at: http://investor.regeneron.com/releasedetail.cfm?releaseid=818844 (Accessed 12 Aug 2017).
62. Thorogood A, Bobe J, Prainsack B, Middleton A, Scott E, Nelson S, et al. APPLaUD: access for patients and participants to individual level uninterpreted genomic data. Hum Genomics. 2018;12:7. https://doi.org/10.1186/s40246-018-0139-5.
63. Sterkx S, Cockbain J. The UK National Health Service's 'innovation agenda': lessons on commercialization and trust. Med Law Rev. 2014;22:221-37.
64. Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, et al. Facilitating a culture of responsible and effective sharing of cancer genome data. Nat Med. 2016;22:464-71. https://doi.org/10.1038/nm.4089.
65. Stein LD, Knoppers BM, Campbell P, Getz G, Korbel JO. Data analysis: create a cloud commons. Nature. 2015;523:149-51. https://doi.org/10.1038/523149a.